Cite
HARVARD Citation
Margolis, D. et al. (2017). Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial. Lancet. 390 (10101), pp. 1499-1510. [Online].